SMORF vs XXII
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SMORF is a Hold and XXII is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
SMORF’s FA Score shows that 1 FA rating(s) are green whileXXII’s FA Score has 0 green FA rating(s).
- SMORF’s FA Score: 1 green, 4 red.
- XXII’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
XXII’s TA Score shows that 3 TA indicator(s) are bullish.
- XXII’s TA Score: 3 bullish, 3 bearish.
Price Growth
SMORF (@Tobacco) experienced а 0.00% price change this week, while XXII (@Tobacco) price change was +2.80% for the same time period.
The average weekly price growth across all stocks in the @Tobacco industry was -4.23%. For the same industry, the average monthly price growth was +2.10%, and the average quarterly price growth was -6.84%.
Reported Earning Dates
XXII is expected to report earnings on Aug 08, 2023.
Industries' Descriptions
@Tobacco (-4.23% weekly)The industry is engaged in the growth, preparation for sale, advertisement, and distribution of tobacco and tobacco-related products like cigarettes. In 2017, tobacco companies spent an estimated $9.36 billion marketing cigarettes and smokeless tobacco in the U.S. – an amount that translates to more than $25 million each day (according to a CDC report). Philip Morris International Inc., Altria Group Inc., and British American Tobacco plc are some major cigar makers. In recent times, vaping or the use of e-cigarette (does not burn tobacco) is gaining momentum – several established cigarette makers are trying to expand their footprint in this new market.
| SMORF | XXII | SMORF / XXII | |
| Capitalization | 9.49B | 5.41M | 175,430% |
| EBITDA | N/A | -23.11M | - |
| Gain YTD | 0.000 | -37.665 | - |
| P/E Ratio | 32.92 | 0.01 | 497,992% |
| Revenue | N/A | 29.8M | - |
| Total Cash | N/A | 5.34M | - |
| Total Debt | N/A | 9.36M | - |
XXII | ||
|---|---|---|
OUTLOOK RATING 1..100 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 64 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 100 | |
PRICE GROWTH RATING 1..100 | 98 | |
P/E GROWTH RATING 1..100 | 94 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| XXII | |
|---|---|
| RSI ODDS (%) | 6 days ago 82% |
| Stochastic ODDS (%) | N/A |
| Momentum ODDS (%) | 6 days ago 90% |
| MACD ODDS (%) | 6 days ago 74% |
| TrendWeek ODDS (%) | 6 days ago 90% |
| TrendMonth ODDS (%) | 6 days ago 90% |
| Advances ODDS (%) | 6 days ago 79% |
| Declines ODDS (%) | 17 days ago 90% |
| BollingerBands ODDS (%) | N/A |
| Aroon ODDS (%) | 6 days ago 90% |
SMORF and
Correlation & Price change
A.I.dvisor indicates that over the last year, SMORF has been loosely correlated with XXII. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SMORF jumps, then XXII could also see price increases.
| Ticker / NAME | Correlation To SMORF | 1D Price Change % | ||
|---|---|---|---|---|
| SMORF | 100% | N/A | ||
| XXII - SMORF | 42% Loosely correlated | +3.76% | ||
| PHPMF - SMORF | 15% Poorly correlated | N/A | ||
| TOBAF - SMORF | 1% Poorly correlated | +7.00% | ||
| BATMF - SMORF | 0% Poorly correlated | N/A | ||
| PYYX - SMORF | -1% Poorly correlated | +12.50% | ||
More | ||||
XXII and
Correlation & Price change
A.I.dvisor indicates that over the last year, XXII has been loosely correlated with SMORF. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if XXII jumps, then SMORF could also see price increases.
| Ticker / NAME | Correlation To XXII | 1D Price Change % | ||
|---|---|---|---|---|
| XXII | 100% | +3.76% | ||
| SMORF - XXII | 42% Loosely correlated | N/A | ||
| RLX - XXII | 11% Poorly correlated | -1.71% | ||
| BTAFF - XXII | 11% Poorly correlated | -0.24% | ||
| KAVL - XXII | 7% Poorly correlated | +3.13% | ||
| TPB - XXII | 5% Poorly correlated | +0.99% | ||
More | ||||